Affitech successfully closed directed offering and received gross proceeds in cash of DKK 26.8 million

Summary:
Affitech have closed the directed offering and received gross proceeds in cash
of DKK 26.8 million. The offering consisted of 133,476,364 shares issued
against contribution in kind shares in Affitech Research AS (former Affitech
AS) and 34,366,225 shares issued against cash payment of the market value of
DKK 0.78 per share of DKK 0.50 directed against certain investors who have
precomitted to subscribe for the shares. The issuance of shares has been
registered at the Danish Commerce and Companies' Agency and Affitech's Articles
of Association have been changed accordingly. 
The cash offering of 34,366,225 shares was carried out as a private placement
at market price of DKK 0.78 per share of DKK 0.50 without preemptive rights to
the existing shareholders. The subscription period for the shares issued
against cash payment commenced on June 30, 2009 at 9.00 a.m. CET and closed on
July 1, 2009 at 5.00 p.m. CET. Payment was made during the subscription period. 

The Offering was not underwritten, but Ferd AS, Arendals Fossekompani ASA,
Braganza AS, Teknoinvest VII KS, Verdane Capital IV TWIN AS, Anchor Secondary 3
Holding AS, Sarsia Life Science Fund AS, Glastad Invest AS, Lene AS, Hans
Bjarne Dahl, John McDougall, Kerstin Maria Hareide, Marike Stassar and Amino AS
had undertaken a binding pre-commitment to the company to subscribe for cash
shares for a total investment of DKK 26.8 million, corresponding to 100% of the
cash offering. 

The newly issued shares are expected to be admitted to trading and official
listing on the NASDAQ OMX on July 6, 2009 under the ISIN of the existing
shares. 


Hørsholm, July 2, 2009


Achim Kaufhold
Chief Executive Officer

Additional information:
Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45
4060 2558